학술논문
686P Next generation sequencing (NGS) helps predict response to immunotherapy (IO) in recurrent or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) patients (pts)
Document Type
Abstract
Author
Mirallas, O.; Marmolejo Castaneda, D.H.; Illescas, D.G.; Gómez-Puerto, D.; Berché, R.; Calvo, A.H.; Vieito Villar, M.; Lorini, L.; Navarro, V.; Assaf Pastrana, J.D.; Saavedra, O.; Alonso, G.; Aguilar Izquierdo, S.; Bescós, C.; Lorente, J.; Giralt, J.; Dienstmann, R.; Garralda, E.; Felip, E.; Brana, I.
Source
In Annals of Oncology September 2022 33 Supplement 7:S856-S857
Subject
Language
ISSN
0923-7534